Blood Cancer

EAA242


Phase Ib/II Fixed Duration Study of Teclistamab/Pomalidomide (TP) versus Carfilzomib/Pomalidomide/Dexamethasone (KPd) in Early Relapse of Multiple Myeloma

Physician and Research Staff Educational Material

This material is intended for promotional use among health care professionals and is NOT intended for use as patient educational material.

ECOG-ACRIN Cancer Research Group